RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
4.920
-0.140 (-2.77%)
At close: Jul 14, 2026, 4:00 PM EDT
4.940
+0.020 (0.41%)
After-hours: Jul 14, 2026, 5:58 PM EDT
RxSight Market Cap
RxSight has a market cap or net worth of $203.67 million as of July 14, 2026. Its market cap has decreased by -60.44% in one year.
Market Cap
203.67M
Enterprise Value
-3.38M
1-Year Change
-60.44%
Ranking
Category
Stock Price
$4.92
Market Cap Chart
Since the IPO on July 30, 2021, RxSight's market cap has decreased from $424.33M to $203.67M, a decrease of -52.00%. That is a compound annual growth rate of -13.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 203.67M | -52.46% |
| Dec 31, 2025 | 428.44M | -69.08% |
| Dec 31, 2024 | 1.39B | -4.17% |
| Dec 29, 2023 | 1.45B | 311.68% |
| Dec 30, 2022 | 351.23M | 14.14% |
| Dec 31, 2021 | 307.73M | -27.48% |
| Jul 30, 2021 | 424.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sight Sciences | 290.55M |
| Senseonics Holdings | 276.15M |
| TriSalus Life Sciences | 259.79M |
| Profound Medical | 258.28M |
| Quantum-Si incorporated | 189.30M |
| Lucid Diagnostics | 189.07M |
| InfuSystem Holdings | 187.69M |
| Owlet | 185.61M |